Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
Ming Zhao
Topics & Concepts
Cytokine stormHydroxychloroquineTocilizumabChloroquineMedicineCoronavirus disease 2019 (COVID-19)CytokineMonoclonal antibodyCytokine release syndromeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakImmunologyAntibodyPharmacologyImmune systemVirologyImmunotherapyRheumatoid arthritisInternal medicineMalariaOutbreakInfectious disease (medical specialty)Chimeric antigen receptorDiseaseCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research